Summary
The production of β- lactamases has constituted the main line of defence of bacteria exposed to β- lactam antibiotics. β- Lactamases may be part of the natural constitution of the cell, acquired by DNA transferred from other bacteria or induced by exposure to a β- lactam antibiotic. Many different types of β- lactamases have been described in a variety of bacteria.
Similar content being viewed by others
References
Cole M. Inhibitors of antibiotic-inactivating enzymes. In Williams JD (Ed.) Antibiotic interactions, pp. 99–131, Academic Press. Orlando, 1979
Moosdeen F. Activity of β-lactamase inhibitors against β-lactamase extracts and β-lactamase-producing organisms. Ph.D. Thesis. University of London, 1986
Philpott-Howard J, Williams JD. Increase in antibiotic resistance in Haemophilus influenzae in the United Kingdom since 1977: a report of study. British Medical Journal 284: 1597–1599, 1982
Williams JD. Epidemiological trends in antibiotic resistance and concerns for the future. In Stuart-Harris C. Harris DM (Eds) The control of antibiotic-resistant bacteria, pp 35–36. Academic Press, London, Orlando. 1982
Williams JD, Drasar FA. Clinical relevance of antibiotic synergy. In Williams JD (Ed.) Antibiotic interactions, pp. 13–25. Academic Press, Orlando, 1979
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Williams, J.D. Importance of β- Lactamases and Clinical Implications of their Inhibitors. Drugs 35 (Suppl 7), 3–11 (1988). https://doi.org/10.2165/00003495-198800357-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-198800357-00003